Heska (NASDAQ:HSKA) will be posting its quarterly earnings results before the market opens on Thursday, May 6th. Analysts expect Heska to post earnings of ($0.16) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.
Heska (NASDAQ:HSKA) last announced its earnings results on Monday, February 22nd. The medical research company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.47. The business had revenue of $64.30 million during the quarter, compared to analyst estimates of $53.10 million. Heska had a negative net margin of 11.15% and a negative return on equity of 2.29%. The firm’s quarterly revenue was up 90.2% on a year-over-year basis. On average, analysts expect Heska to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of HSKA opened at $191.14 on Wednesday. The firm has a market cap of $1.99 billion, a PE ratio of -86.10 and a beta of 1.65. The company has a current ratio of 4.96, a quick ratio of 3.79 and a debt-to-equity ratio of 0.18. The firm has a fifty day simple moving average of $176.86 and a two-hundred day simple moving average of $158.49. Heska has a 1-year low of $68.04 and a 1-year high of $217.17.
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps.
Featured Article: Investing strategies using the yield curve
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.